ashish rajanibhai patel's Insider Trades & SAST Disclosures
ashish rajanibhai patel's most recent trade in Lincoln Pharmaceuticals Ltd. was a Acquisition of 293,100 Equity Shares done at an average price of Rs. 502.7 . Disclosure was reported to the exchange on Sept. 27, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
ashish rajanibhai patel's has made SAST transactions in Lincoln Pharmaceuticals Ltd. recently where a Acquisition of 18,200 shares done . Disclosure was reported to the exchange on Sept. 6, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern ashish rajanibhai patel.To see full superstar portfolios of large investors like Jhunjhunwala, Damani and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter Group | Acquisition | 27 Sep 2023 | 293,100 | 2,122,902 (10.60%) | 1.46% | 502.7 | 147,341,370 | 26 Sep 2023 26 Sep 2023 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 12 Sep 2023 | 18,200 | 1,829,802 (9.13%) | 0.09% | - | 05 Sep 2023 05 Sep 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 11 Sep 2023 | 29,300 | 1,811,602 (9.04%) | 0.15% | - | 01 Sep 2023 01 Sep 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 08 Sep 2023 | 29,500 | 1,782,302 (8.90%) | 0.15% | - | 29 Aug 2023 29 Aug 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 06 Sep 2023 | 18,200 | 1,829,802 (9.14%) | 0.09% | 522.5 | 9,509,318 | 05 Sep 2023 05 Sep 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 05 Sep 2023 | 31,500 | 1,691,302 (8.44%) | 0.15% | - | 22 Aug 2023 22 Aug 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 01 Sep 2023 | 29,300 | 1,811,602 (9.04%) | 0.15% | 512.1 | 15,003,944 | 01 Sep 2023 01 Sep 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 31 Aug 2023 | 31,500 | 1,691,302 (8.44%) | 0.15% | - | 22 Aug 2023 22 Aug 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 29 Aug 2023 | 29,500 | 1,782,302 (8.90%) | 0.15% | 505.5 | 14,911,660 | 29 Aug 2023 29 Aug 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 25 Aug 2023 | 30,500 | 1,721,802 (8.59%) | 0.15% | 487.9 | 14,881,865 | 24 Aug 2023 24 Aug 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 25 Aug 2023 | 31,000 | 1,752,802 (8.75%) | 0.15% | 481.2 | 14,915,650 | 25 Aug 2023 25 Aug 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 23 Aug 2023 | 31,500 | 1,691,302 (8.44%) | 0.16% | 471.0 | 14,837,445 | 22 Aug 2023 22 Aug 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 18 Jul 2023 | 22,000 | 1,659,802 (8.29%) | 0.11% | - | 26 Jun 2023 26 Jun 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 11 Jul 2023 | 55,500 | 1,637,802 (8.18%) | 0.28% | - | 19 Jun 2023 21 Jun 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 06 Jul 2023 | 38,500 | 1,582,302 (7.90%) | 0.19% | - | 15 Jun 2023 16 Jun 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 27 Jun 2023 | 39,000 | 1,543,802 (7.71%) | 0.20% | - | 12 Jun 2023 13 Jun 2023 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 27 Jun 2023 | 22,000 | 1,659,802 (8.29%) | 0.11% | 407.3 | 8,961,480 | 26 Jun 2023 26 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 21 Jun 2023 | 22,000 | 1,637,802 (8.18%) | 0.11% | 398.4 | 8,764,580 | 21 Jun 2023 21 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 21 Jun 2023 | 8,500 | 1,615,802 (8.07%) | 0.04% | 400.5 | 3,404,505 | 20 Jun 2023 20 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 21 Jun 2023 | 25,000 | 1,607,302 (8.02%) | 0.12% | 395.4 | 9,886,000 | 19 Jun 2023 19 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 16 Jun 2023 | 8,500 | 1,582,302 (7.90%) | 0.04% | 390.9 | 3,322,650 | 16 Jun 2023 16 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 16 Jun 2023 | 30,000 | 1,573,802 (7.86%) | 0.15% | 390.1 | 11,703,000 | 15 Jun 2023 15 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter Group | Acquisition | 13 Jun 2023 | 9,000 | 1,543,802 (7.71%) | 0.04% | 387.6 | 3,488,400 | 13 Jun 2023 13 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter Group | Acquisition | 13 Jun 2023 | 30,000 | 1,534,802 (7.66%) | 0.15% | 384.4 | 11,531,400 | 12 Jun 2023 12 Jun 2023 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 09 Dec 2022 | 15,500 | 1,504,802 (7.51%) | 0.08% | - | 08 Dec 2022 08 Dec 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 09 Dec 2022 | 25,000 | 1,489,302 (7.43%) | 0.12% | - | 05 Dec 2022 05 Dec 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter Group | Acquisition | 08 Dec 2022 | 15,500 | 1,504,802 (7.51%) | 0.08% | 356.5 | 5,525,750 | 08 Dec 2022 08 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 07 Dec 2022 | 25,000 | 1,489,302 (7.43%) | 0.12% | 341 | 8,525,000 | 05 Dec 2022 05 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 06 Dec 2022 | 31,000 | 1,464,302 (7.31%) | 0.16% | - | 28 Nov 2022 28 Nov 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 30 Nov 2022 | 31,000 | 1,464,302 (7.31%) | 0.15% | 328.3 | 10,175,750 | 28 Nov 2022 28 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 29 Nov 2022 | 62,500 | 1,433,302 (7.15%) | 0.31% | - | 21 Nov 2022 22 Nov 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 23 Nov 2022 | 31,500 | 1,433,302 (7.15%) | 0.16% | 321.9 | 10,139,850 | 22 Nov 2022 22 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 23 Nov 2022 | 31,000 | 1,401,802 (6.99%) | 0.15% | 321.5 | 9,966,500 | 21 Nov 2022 21 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 22 Nov 2022 | 33,000 | 1,370,802 (6.84%) | 0.16% | - | 16 Nov 2022 16 Nov 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 18 Nov 2022 | 33,000 | 1,370,802 (6.84%) | 0.16% | 299.3 | 9,875,250 | 16 Nov 2022 16 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 16 Jun 2022 | 33,000 | 1,337,802 (6.67%) | 0.16% | - | 14 Jun 2022 14 Jun 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 14 Jun 2022 | 33,000 | 1,337,802 (6.67%) | 0.16% | 299.7 | 9,890,100 | 14 Jun 2022 14 Jun 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 10 Jun 2022 | 35,000 | 1,304,802 (6.51%) | 0.17% | - | 08 Jun 2022 08 Jun 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 10 Jun 2022 | 35,000 | 1,304,802 (6.51%) | 0.17% | 290.1 | 10,153,850 | 08 Jun 2022 08 Jun 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 07 Jun 2022 | 35,000 | 1,269,802 (6.34%) | 0.17% | 288.0 | 10,080,350 | 07 Jun 2022 07 Jun 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 07 Jun 2022 | 34,500 | 1,234,802 (6.16%) | 0.17% | 287.6 | 9,922,200 | 06 Jun 2022 06 Jun 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 03 Jun 2022 | 20,500 | 1,200,302 (5.99%) | 0.10% | 290.1 | 5,946,025 | 02 Jun 2022 02 Jun 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 10 Dec 2021 | 33,500 | 1,179,802 (5.90%) | 0.17% | - | 09 Dec 2021 09 Dec 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 10 Dec 2021 | 33,500 | 1,179,802 (5.90%) | 0.17% | 373.3 | 12,503,875 | 09 Dec 2021 09 Dec 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 07 Dec 2021 | 30,000 | 1,146,302 (5.73%) | 0.15% | - | 06 Dec 2021 06 Dec 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 07 Dec 2021 | 30,000 | 1,146,302 (5.73%) | 0.15% | 354.9 | 10,647,000 | 06 Dec 2021 06 Dec 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 02 Dec 2021 | 35,500 | 1,116,302 (5.58%) | 0.18% | - | 30 Nov 2021 01 Dec 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 02 Dec 2021 | 10,500 | 1,116,302 (5.58%) | 0.05% | 327.5 | 3,438,330 | 01 Dec 2021 01 Dec 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 02 Dec 2021 | 25,000 | 1,105,802 (5.53%) | 0.13% | 326 | 8,150,000 | 30 Nov 2021 30 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 29 Nov 2021 | 24,000 | 1,080,802 (5.40%) | 0.12% | - | 24 Nov 2021 24 Nov 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 26 Nov 2021 | 24,000 | 1,080,802 (5.40%) | 0.12% | 338.5 | 8,122,800 | 24 Nov 2021 24 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 20 Nov 2021 | 25,000 | 1,056,802 (5.28%) | 0.13% | - | 18 Nov 2021 18 Nov 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 19 Nov 2021 | 25,000 | 1,056,802 (5.28%) | 0.13% | 328.6 | 8,215,250 | 18 Nov 2021 18 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter | Acquisition | 29 Sep 2021 | 31,000 | 1,031,802 (5.16%) | 0.16% | - | 27 Sep 2021 27 Sep 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 29 Sep 2021 | 31,000 | 1,031,802 (5.16%) | 0.16% | 378.4 | 11,729,470 | 27 Sep 2021 27 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 06 Sep 2021 | 35,000 | 1,000,802 (5%) | 0.18% | 334.9 | 11,719,750 | 06 Sep 2021 06 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 06 Sep 2021 | 35,000 | 1,000,802 (5%) | 0.18% | - | 06 Sep 2021 06 Sep 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 04 Sep 2021 | 35,000 | 965,802 (4.83%) | 0.18% | - | 01 Sep 2021 01 Sep 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 03 Sep 2021 | 35,000 | 965,802 (4.83%) | 0.18% | 327.1 | 11,448,850 | 01 Sep 2021 01 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 30 Aug 2021 | 35,000 | 930,802 (4.65%) | 0.18% | - | 25 Aug 2021 25 Aug 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 27 Aug 2021 | 35,000 | 930,802 (4.65%) | 0.18% | 327.3 | 11,456,900 | 25 Aug 2021 25 Aug 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 21 Aug 2021 | 26,000 | 895,802 (4.48%) | 0.13% | 325.9 | 8,474,180 | 20 Aug 2021 20 Aug 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 16 Aug 2021 | 15,000 | 869,802 (4.35%) | 0.08% | 338.2 | 5,072,250 | 13 Aug 2021 13 Aug 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 23 Feb 2021 | 116,000 | 854,802 (4.27%) | 0.58% | - | 19 Feb 2021 23 Feb 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 23 Feb 2021 | 26,000 | 854,802 (4.27%) | 0.13% | 224.4 | 5,833,880 | 23 Feb 2021 23 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 23 Feb 2021 | 30,000 | 828,802 (4.14%) | 0.15% | 224.0 | 6,720,600 | 22 Feb 2021 22 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 23 Feb 2021 | 60,000 | 798,802 (3.99%) | 0.30% | 224.5 | 13,471,800 | 19 Feb 2021 19 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 17 Feb 2021 | 64,000 | 738,802 (3.69%) | 0.32% | 218.3 | 13,969,280 | 17 Feb 2021 17 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 17 Feb 2021 | 25,000 | 674,802 (3.37%) | 0.13% | 219.9 | 5,497,000 | 16 Feb 2021 16 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 17 Feb 2021 | 89,000 | 738,802 (3.69%) | 0.44% | - | 16 Feb 2021 17 Feb 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter | Acquisition | 15 Feb 2021 | 50,000 | 649,802 (3.25%) | 0.25% | - | 12 Feb 2021 15 Feb 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 15 Feb 2021 | 25,000 | 649,802 (3.25%) | 0.13% | 221.4 | 5,535,750 | 15 Feb 2021 15 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel | Promoter & Director | Acquisition | 15 Feb 2021 | 25,000 | 624,802 (3.12%) | 0.13% | 220.4 | 5,509,000 | 12 Feb 2021 12 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Ashish Rajanibhai Patel & PACs | Promoter | Acquisition | 09 Feb 2021 | 70,000 | 599,802 (3%) | 0.35% | - | 05 Feb 2021 05 Feb 2021 |
SAST (29(2)) | - | Market |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.